Pacific Biosciences of California, Inc.
$1.31
The Read: Pacific Biosciences has historically experienced severe stock moves averaging about 23%, driven primarily by disappointing forward guidance, revenue misses, and investor concerns over dilution despite operational milestones and earnings beats.
Price
Overlays
Panel
PACB
Hover to view data
No Data